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ABSTRACT 14 
Taste masking of bitter active substances is an emerging area in the pharmaceutical industry 15 
especially for paediatric/geriatric medications.  In this study we introduce the use of jet – 16 
dispensing as a taste masking technology by printing mucosal thin films of three model bitter 17 
substances, Cetirizine HCl, Diphenylhydramine HCl and Ibuprofen. The process was used to 18 
dispense aqueous drugs/polymer solutions at very high speed where eventually the drugs 19 
were embedded in the polymer matrix. The in vivo evaluation of jet – dispensed mucosal 20 
films showed excellent taste masking for drug loadings from 20 - 40%. Jet dispensing was 21 
proved to make uniform, accurate and reproducible thin films with excellent content 22 
uniformity. 23 
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Printing technologies have been primarily used by the electronic industry but recently 28 
have been adopted for the fabrication of pharmaceutical dosage forms and drug delivery 29 
systems (Kolakovic et al. 2013). Applications include printing of dosage forms on porous 30 
substrates (Sandler et al. 2011), controlled release of active substances (Genina et al. 2012), 31 
multilayer film coatings (Preis et al. 2015, Buanz et al. 2014), microparticles (Sharma et al. 32 
2013) bioprinting (Chang et al. 2011) or even transdermal microneedles (Uddin et al. 2015). 33 
A major advantage of printing technologies is the potential to be used for future fabrication of 34 
on – demand individualized medicines and regenerative medicines. 35 
Jet dispensing is a technology that can dispense continuously liquids with a wider 36 
range of viscosities by moving the nozzle at high speeds across the x-axis and the stage 37 
across y-axis to cover all coordinates and jetting precise volume of dots. According to this 38 
technology (Fig. 1a,b), the jetting device operates in a continuous mode by using a pneumatic 39 
piston with a ball tip end to push fluid through a narrow orifice at the jet nozzle tip. The 40 
application of electrical signal triggers a solenoid, which allows air pressure to apply force on 41 
a ball-needle through a piston – seal. As the ball-needle is lifted from its seat, fluid is allowed 42 
to flow down and around the ball-needle tip. At the end of the electrical impulse, the solenoid 43 
discharges, releasing the air pressure allowing the force form the compressed spring to slam 44 
the ball-needle tip back down into its seat, separating and ejecting a dot from the fluid. By 45 
using the ball and seat design the coating solution fills the void left by the ball as it retracts 46 
from the seat. As the ball returns, the force due to acceleration breaks the stream of the drug – 47 
polymer solution, which is jetted through the nozzle. The broken stream of the solution 48 
strikes the substrate from a distance of 1.0mm to 3.5 mm above the board and forms an 49 
adhesive dot.  50 
As shown in Fig. 1c we employed a laboratory DispenseMate 583 dispenser (Nordson  51 
- Asymtek, Maastricht, Netherlands) for the printing of taste masked mucosal films by using 52 
Cetirizine HCl (CTZ), Diphenylhydramine HCl (DPD) and Ibuprofen (IBU) as model drugs 53 
(Sigma, Gillingham, UK). A typical experiment comprised of ethanolic solutions of Eudragit 54 
EPO (Evonik Industries, Darmastadt, Germany) and CTZ or DPD or IBU at polymer/drug 55 
ratios of 90:10, 80:20 and 60:40 (wt/wt) printed on the dispenser’s stage. CTZ and DPD are 56 
extremely bitter drugs and taste masking is quite difficult to achieve. In order to create the 57 
films, the solution was jetted in several parallel lines. For the purposes of the study the nozzle 58 
was moving in 9mm/sec jetting 1drop/0.03sec. The fluid pressure used was 11.4bar and the 59 
nozzle 100µm. The size of the ball tip and the seat was 2.4mm and 0.32µm respectively. 60 
However, these settings can be altered according to solutions’ properties and the film 61 
specifications. The parameter adjustments affect the dots in two different ways, either by 62 
changing properties of the fluid, or by changing mechanical properties of the jet. The nozzle 63 
orifice, the size of the seat, the size of the needle and the fluid pressure of the dispensed 64 
solution determines the droplets’ size for given dispensing solution. The solution viscosities 65 
were kept at 30-50cP but highly viscous solution of 10,000cP can be easily printed by 66 
increasing the system pressure. 67 
By applying jet dispensing we printed successfully EPO/CTZ, EPO/DPD and 68 
EPO/IBU thin films that can be used for drug mucosal delivery. As shown in Fig. 2 the films 69 
were printed with high accuracy, reproducibility and uniformity. The films appear glossy 70 
with a smooth surface even at high drug loadings ensuring high level of patient compliance.  71 
Ethanol evaporated instantly resulting in rapid film printing without further downstream 72 
processing. It is obvious that by adjusting the film dimensions the drug printed amounts can 73 
be easily tuned and adjusted to individual patient needs.  74 
Fig. 3 depicts the differential scanning calorimetry (Mettler Toledo 823e, Greifensee, 75 
Switzerland) analysis, which revealed a glass transition at 58.17oC for EPO and melting 76 
endotherms at 225.59oC, 170.83oC and 77.36oC for CTZ, DPD and IBU respectively.  In 77 
contrast, the DSC thermograms of all printed films showed the absence of drug melting peaks 78 
suggesting that all substances are in amorphous state in the polymer matrix. This resulted in 79 
high drug release rates (pH 7.4) from the films especially for the water insoluble IBU. The 80 
fact that EPO is highly permeable in pH >5 led to immediate release of the other two drugs 81 
(CTZ, DPD) as well.  The highly water soluble CTZ and DPD were released within the first 5 82 
min. From Fig. 4 it can be seen that EPO/IBU (60:40) demonstrated faster release rate 83 
compared to EPO/IBU (80:40). This has been previously observed and is attributed in strong 84 
intermolecular drug – polymer interactions through H-bonding (Gryczke et al. 2011). 85 
Nevertheless, IBU showed rapid release rates within 10min for both formulations.  The film 86 
drug loadings were 20mg for CTZ/DPD and 50mg for IBU. Dissolution studies are carried 87 
out for all the formulations, employing USP dissolution apparatus at 37 ± 0.5oC, rotated at 88 
constant speed of 50 rpm using 900 mL of simulative saliva (pH 7.4). The drug content 89 
uniformity was also evaluate for the printed films and it was found be excellent for all 90 
formulations with standard deviations varying from ±0.01 – 0.02mg (Madhavi et al. 2013). 91 
In vivo taste masking evaluation of the printed films (Code of Ethics of the World 92 
Medical Association, Declaration of Helsinki) was performed on 10 healthy human 93 
volunteers. The films were held in the mouth for a period of 2min and then spat out. The 94 
bitterness was recorded immediately according to the bitterness intensity scale from 1 to 5, 95 
where 1, 2, 3, 4 and 5 indicate none, threshold, moderate, bitter and strong bitterness. Films 96 
did not disintegrate rapidly due to the EPO polymer, which requires pH<5 to dissolve. Fig. 5 97 
shows that the perceived taste intensity studies in human volunteers showed complete taste 98 
masking for all drugs. The recorded bitterness scores were of 1 for the thin films, 3 for IBU 99 
and 5 for CTZ/DPD. Interestingly, the taste masking score was the same for the both IBU 100 
films with low and high drug loadings. The effective taste masking for all bitter drugs is 101 
attributed to the intermolecular interactions between the drug-polymer functional groups. 102 
In conclusion, we demonstrated the efficiency of jet – dispensing to print rapidly oral 103 
thin films for mucosal delivery with excellent taste masking of bitter active substances. The 104 
technology can produce rapidly films with high palatability due to the printing 105 
reproducibility, uniformity and surface smoothness. Jet dispensing is versatile and it can print 106 
a wide range of drugs–polymer solutions by combining several polymers of various 107 
viscosities (e.g. mucoadhesive). Furthermore, it is feasible to tune the loading, release rates 108 
and dose of the drug substance and the film dimensions. The technology can be easily scaled 109 
– up for commercial purposes and manufacturing of robust taste masked thin films with 110 
future applications in personalized medicines.  111 
 112 
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